Fritextsökning
Innehållstyper
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Swedish life science in political focus
It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Lösningsmedelsavdunstare som klarar höga kokpunkter
Torkning. Den nya EZ-2 Elite har utvecklats för att ta bort lösningsmedel med extra höga kokpunkter vilket ska hjälpa användaren att slutgiltigt torka även myck...
-
Safe and economic dispensing of powders
Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.
-
This is Sweden's largest life science region
About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Showroom for free
The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Martin Willner, Manager Lab, Nordic Service Manager, Mettler-Toledo AB
Why are you going to Scanlab+Biotech Forum?
-
Hon utvecklar teknik för hälsodata
E-hälsa är inte i stället för vård. Det är en möjlighet att ta ansvar för att den medicin som man äter ska göra mest möjliga nytta. Det menar forskaren Sara Rig...
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
BREAKING